GlassScriptPhysician profile
Edward M Jung
NPI 1750346417
$1,428.12
in general payments reported to CMS, 2019-2025
23 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $283 · 2021: $14.63 · 2022: $320 · 2023: $38.59 · 2024: $52.10 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $239.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $177.57 | 2019-2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $159.67 | 2019-2023 | |
| Abbvie INC. | $149.09 | 2021-2022 | |
| Amgen INC. | $93.31 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $72.70 | 2019 | |
| Pfizer INC. | $61.72 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.41 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.03 | 2019-2022 | |
| Amarin Pharma, INC. | $57.31 | 2019-2020 | |
| Medtronic, INC. | $52.10 | 2024 | Stealth Autoguide System |
| Lilly USA, LLC | $38.97 | 2019-2022 | |
| Abbott Laboratories | $37.50 | 2019 | |
| Merck Sharp & Dohme LLC | $32.76 | 2019-2023 | Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $29.82 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19.34 | 2022 | |
| Pulmonx Corporation | $14.64 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.63 | 2022 | |
| Boston Scientific Corporation | $13.35 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.58 | 2022 | |
| Astellas Pharma US INC | $12.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.81 | 2020 | |
| Allergan, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.